Thu, Sep 18, 2014, 3:59 PM EDT - U.S. Markets close in 1 min.


% | $
Quotes you view appear here for quick access.

Epizyme, Inc. Message Board

  • rob_cos rob_cos Feb 11, 2014 8:51 PM Flag

    Epizyme Announces Exercise of Underwriters' Option to Purchase Additional Shares of Common Stock --- Nice demand

    Epizyme Announces Exercise of Underwriters' Option to Purchase Additional Shares of Common Stock --- Nice demand

    CAMBRIDGE, Mass., Feb. 11, 2014 /PRNewswire/ -- Epizyme, Inc. (EPZM), a clinical stage biopharmaceutical company that is discovering, developing and planning to commercialize innovative personalized therapeutics for patients with genetically defined cancers, today announced that, following the initial closing of its recent public offering on February 10, 2014, the underwriters for the offering exercised in full their option to purchase 673,901 additional shares of common stock from the Company at the public offering price of $29.25 per share, less underwriting discounts. The sale of the additional shares is expected to close on or about February 12, 2014, subject to customary closing conditions.

    A registration statement relating to the offering was filed with and declared effective by the U.S. Securities and Exchange Commission.

    Citigroup, Cowen and Company, LLC and Leerink Partners LLC are acting as joint book-running managers for the offering. JMP Securities LLC, Wedbush Securities Inc. and BTIG LLC are acting as co-managers for the offering. The offering is being made only by means of a prospectus, copies of which, when available, may be obtained from Citigroup, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by phone at 800-831-9146; Cowen and Company, LLC, c/o Broadridge Financial Services, 1155 Long Island Avenue, Edgewood, NY 11717, Attention: Prospectus Department, phone (631) 274-2806, fax (631) 254-7140; or Leerink Partners LLC, Attention: Syndicate Department, One Federal Street, 37th Floor, Boston, MA 02110, or by email at or by phone at 1-800-808-7525.

    This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such

27.31-0.36(-1.30%)3:59 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.